Testing effectiveness (Phase 2)Study completedNCT04945460
What this trial is testing
Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
Who this might be right for
Hypertension, Pulmonary
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 164